ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer.

International Journal of Surgical Oncology
Sonar Soni PanigoroZafiral Azdi Albar

Abstract

Breast cancer is the most common cancer with an increasing incidence in Asia. About 20% of all breast cancers are triple-negative breast cancers (TNBCs). BCSC is a subset of tumor cells that has stem cell-like characteristics, such as a high capacity for self-renewal and tumor initiation, which implies that BCSC may cause aggressiveness of TNBC. ALDH1 has a role in early stem cell differentiation through its function in the oxidation of retinol to retinoic acid, proposed to be a strong candidate for breast cancer stem cells. Various studies have shown that ALDH1 is one of the markers of CSC that can be used as a prognosis indicator because it can be a biological marker for poor prognostic factors in TNBC. This study assessed the prognostic survival rate with a retrospective cohort method in TNBC patients. A total of 54 of 55 patients treated at RSCM were tested for the expression of ALDH1 through an immunohistochemistry assay of breast cancer tissue using ALDH1 staining. Survival analysis was done to obtain the prognostic data of ALDH1. Positive ALDH1 expression was obtained at 38.89% in TNBC patients. One-year survival and three years of survival in TNBC patients with positive ALDH1 expression were 42.9% and 33.3%, respectivel...Continue Reading

References

May 25, 2006·Journal of Clinical Laboratory Analysis·Wojciech JelskiMaciej Szmitkowski
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tomonori TaneiShinzaburo Noguchi
Jun 24, 2010·Breast Cancer Research and Treatment·Liheng ZhouJinsong Lu
Feb 10, 2011·The Oncologist·Charles M Perou
Jul 13, 2013·Human Pathology·Ling ZhouQian Huang
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Dec 24, 2015·Current Opinion in Obstetrics & Gynecology·Sara Hurvitz, Monica Mead
Oct 28, 2016·Breast Cancer : Targets and Therapy·Brett FleisherSihem Ait-Oudhia
Aug 8, 2018·Clinical Medicine Insights. Oncology·Homero GonçalvesMaria Teresa Bustamante Teixeira

❮ Previous
Next ❯

Citations

Sep 24, 2020·Diagnostics·Clarence Ching Huat KoGeok Chin Tan
Jun 21, 2021·Seminars in Cancer Biology·Zhan HuaJianjun Zhou

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.